FOLFOXFOLFIRI5-FUoxaliplatinirinotecanCRCcolorectal cancer
… differential treatment responses (figure 3):First-line therapy FOLFOX: tumor progression in metastatic lesions.Second-line therapy FO…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 3,841–3,900 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
medical hormonal treatment1medical interventions1medical termination1medical therapies1medically managed1medication management1medication optimisation1medication rationalisation1medication regimens1medication treatment1medicines1medium-chain triglyceride supplementation1melphalan autograft1membrane peel1meningioma radionuclide therapy1meniscoplasty1menopausal hormone replacement therapy1menopausal hormone therapies1menopause treatments1mental healthcare1mentalisation-based therapy1mesh surgery1metabolic and bariatric surgery1metabolic correction1methadone maintenance treatment1microbiome-based therapeutics1microinvasive pars plana vitrectomy1microlaryngeal surgery with cold knife excision1micronutrient and macronutrient supplementation1microsurgical ligation1migraine prophylaxis1migraine prophylaxis treatment1mindfulness cognitive–behavioural therapy1mindfulness training1mindfulness-based interventions1mini-trochleoplasty1minimally invasive interventions1minimally invasive surgical management1mitochondrial transplantation1mitochondrial transplants1mitoxantrone-based reinduction chemotherapy1moderate corticosteroid therapy1moderate–high-efficacy DMTs1modern medical therapy1modern pharmacotherapy1modern therapy1modified O’Connor technique1modulated aspiration thrombectomy1molecular therapies1monoclonal antibody therapy1mouthwash1mucolytics1multicomponent exercise1multidisciplinary care1multidisciplinary care approaches1multidisciplinary counselling1multidisciplinary involvement1multidisciplinary therapy1multidisciplinary treatment1multidrug TB therapy1
Articles mentioning treatments
7,227 articles · page 229 of 603cancer vaccinesimmune checkpoint inhibitorsCOVID-19CellCartaOlink Reveal10x Genomics
…apies, such as immune checkpoint inhibitors, CAR-T cells, TILs, cancer vaccines, and T cell engagers/redirectors, work by inducing a robust T c…
cancer treatmentFDAInternational Council for HarmonisationFDA-recommended
…he development and quality control of cell therapy products for cancer treatment. As advanced therapies expand into clinical oncology, there is …
81.1%
radioimmunotherapieschimeric antigen receptor (CAR)-T cell therapiescancerOSU cohort3
…ntibodies (mAbs), antibody-drug conjugates (ADCs), bispecifics, radioimmunotherapies, and chimeric antigen receptor (CAR)-T cell therapies. 1 Howeve…
ASP-1929 PITHNSCCcuSCCPembrolizumabNational Institutes of HealthIRDye®700DXASP-1929NIH
…s Across Patients Show Consistent Immune Cell Changes Following ASP-1929 PIT. Uniform Manifold Approximation and Projection (UMAP) plot show…
CAR-T therapySolid tumorsPD-L1-EphA2-4-1BBPD-L1-EphA2-CD28EphA2-PD-L1-4-1BBPD-L1-EphA2EphA2-PD-L1-CD28
…findings support the clinical development of PD-L1-EphA2 tandem CAR-T therapy for treating solid tumors expressing either or both antigens, a…
249 CD3ε enhances CAR-T fitness and persistence by promoting the survival of effector memory T cells
CAR-T therapyCAR-T Cell TherapyB-cell malignanciesAAALAC-approved facilityCAR-T
…Background CAR-T therapy has demonstrated potent anti-tumor efficacy in treating a range…
CAR-T cell therapyCAR T cell therapyPancreatic Ductal Adenocarcinomapancreatic cancerMass General Brighamsolid tumorsMGH Cancer CenterAmerican-Italian Cancer FoundationCRIS Foundation Out-Back Fellowship Programmerotein+2 more
…Background CAR-T cell therapy has shown limited efficacy in solid tumors due to factors such …
CAR-T cell immunotherapiesCAR T cell immunotherapiessolid tumors
…Background CAR-T cell immunotherapies are being avidly pursued for treatment of solid tumors. However…
immune checkpoint blockadestandard treatmentsUniversity Hospital TübingenGerman Cancer Research CenterNUT carcinomaB7-H3NGS Core FacilityOmics IT and Data Management Core FacilityDKFZB7-H3-targeted
…nreported immunologically ‘hot’ NC tumors that may benefit from immune checkpoint blockade and other immunotherapies. To uncover novel actionable targets …
ACTsolid tumorshematologic cancersmetastatic melanomaRNF166
…highlighting a promising strategy for improving the efficacy of ACT.Abstract 277 Figure 1Comprehensive analysis of proteome turnove…
Trispecific NK cell engagersantibody-drug conjugatesUniversity of MinnesotacancerJackson Laboratoryhuman IL-15
…umors and evaluated against various IO therapies such as CAR T, Trispecific NK cell engagers, and antibody-drug conjugates.Results CD34 NSG-FLT3-IL15 mice e…